Nippon Medical School · Chiba Hokuso Hospital

Research keywordsacute myeloid leukemia・natural killer cell therapy・DNAM-1 and CD112 axis・malignant lymphoma・MEAM conditioning regimen・circulating cell-free DNA・multiple myeloma

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Shunsuke Yui, Satoshi Wakita, Yasunobu Nagata, Yasuko Kuribayashi, Toshio Asayama, Yusuke Fujiwara, Masahiro Sakaguchi, Satoshi Yamanaka, Atsushi Marumo, Ikuko Omori, Ryosuke Kinoshita, Daishi Onai, Mika Sunakawa, Yuta Kaito, Kazuki Inai, Taichiro Tokura, Atsushi Takeyoshi, Shunichi Yasuda, Shunsuke Honma, Kazutaka Nakayama, Tsuneaki Hirakawa, Kunihito Arai, Tomoaki Kitano, Muneo Okamoto, Koiti Inokuchi, Hiroki Yamaguchi論文
• Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.論文
• Unrelated Bone Marrow Transplantation for Chronic Myeloid Leukemia after Liver Transplantation.論文
• 掲載種別：論文

• 急性骨髄性白血病に対するBCL2阻害剤と免疫療法による新規治療の開発2024 · 研究課題/領域番号： 24K23366 2024年7月 - 2026年3月

• Official profile